骨髄移植市場：タイプ別、治療タイプ別、エンドユーザー別-2025-2030年の世界予測

骨髄移植市場は、2023年に162億7,000万米ドルと評価され、2024年には176億2,000万米ドルに達すると予測され、CAGR 8.74％で成長し、2030年には292億6,000万米ドルになると予測されています。

骨髄移植（BMT）は、白血病、リンパ腫、その他の血液疾患などの治療に不可欠な、損傷または病気の骨髄を健康な骨髄幹細胞と置き換えることを含みます。自家移植、同種移植、合遺伝子移植があり、それぞれ異なる臨床要件に対応しているため、様々な血液疾患や免疫不全疾患への適用が拡大しています。これらの疾患の有病率の増加は、BMTの必要性と適用を迫っており、さらに医療技術の進歩と政府の支援政策が後押ししています。BMTに関する認知度の向上、成功率の改善、幹細胞ドナーの増加などが成長に大きく影響しています。しかし、高額な手術費用、厳しい規制、移植片対宿主病のような合併症のリスクといった課題に直面しており、これが市場の成長軌道を制限する可能性があります。

最終用途の範囲は、主に病院、診療所、専門のがん治療センターであり、治療効果と患者の転帰を高めるために高度なBMT施設への投資が増加しています。最近の市場開拓の動向から、遺伝子マッチング技術や幹細胞の凍結保存に潜在的なビジネスチャンスがあることが明らかになっています。この分野の企業は、個別化医療やドナー・レシピエント照合システムの物流改善に注力することで、こうした動向を活用することができます。さらに、移植後の合併症を軽減するための技術革新は、業界の利害関係者にとって貴重な研究開発の道を提供します。制限を緩和するためには、費用対効果の高い治療プロトコルと患者中心のケアモデルが急務です。

市場の性質はダイナミックであり、再生医療とゲノミクスの調査への傾倒が強く、技術革新のための肥沃な土壌を提供しています。治療計画における人工知能の統合や、診察における遠隔医療の活用に注力する企業は、アクセシビリティと業務効率を高めることができます。イノベーションを促進するために学術研究機関との連携を優先することで、利害関係者は競争力を確保することができます。このように、免疫療法の進歩をターゲットとし、世界のドナー登録を強化し、一般向け啓発キャンペーンに投資することは、新たな市場機会を捉え、BMT市場の持続的成長を促進するための戦略的ステップです。

市場力学：急速に進化する骨髄移植市場の主要市場インサイトを公開

骨髄移植市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 血液がんの蔓延と、血液がんへのアクセスの向上骨髄移植
  • 細胞療法および組織工学製品の商業化の増加
  • 治療法の認知度向上に向けた政府の取り組み
• 市場抑制要因
  • 治療費の高騰と償還不足
• 市場機会
  • 骨髄移植療法における技術の進歩
  • BMTの継続的な研究開発活動
• 市場の課題
  • GVHD、感染症、再発に関する懸念

ポーターの5つの力：骨髄移植市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：骨髄移植市場における外部からの影響の把握

外部マクロ環境要因は、骨髄移植市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析骨髄移植市場における競合情勢の把握

骨髄移植市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス骨髄移植市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、骨髄移植市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨骨髄移植市場における成功への道筋を描く

骨髄移植市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 血液がんの有病率とアクセス性の向上骨髄移植
    • 細胞治療および組織工学製品の商業化の増加
    • 治療法の認知度向上に向けた政府の取り組み
  • 抑制要因
    • 治療費が高額で、補償がない
  • 機会
    • 骨髄移植治療における技術的進歩
    • BMTの継続的な研究開発活動
  • 課題
    • GVHD、感染症、再発に関する懸念
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 骨髄移植市場：タイプ別

• 同種移植
• 自家移植

第7章 骨髄移植市場治療の種類別

• 再生不良性貧血
• 白血病
• リンパ腫
• 骨髄異形成症候群
• 骨髄腫
• 骨髄増殖性疾患
• 鎌状赤血球貧血
• 固形腫瘍
• サラセミア

第8章 骨髄移植市場：エンドユーザー別

• 外来手術センター
• 病院
• 多科クリニック

第9章 南北アメリカの骨髄移植市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の骨髄移植市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの骨髄移植市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• American Type Culture Collection
• Bayer AG
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Bristol Myers Squibb
• Eli Lilly and Company
• FUJIFILM Cellular Dynamics, Inc.
• Gamida Cell
• Hemacare Corporation
• Lifeline Cell Technology
• Lonza Group AG
• Magenta Therapeutics, Inc.
• Merck KgaA
• Mesoblast Ltd.
• Novartis AG
• PromoCell GmbH
• Qiagen N.V.
• ReeLabs Pvt. Ltd.
• Sanofi-Aventis LLC
• ScienCell Research Laboratories, Inc.
• STEMCELL Technologies Inc.

LIST OF FIGURES

• FIGURE 1. BONE MARROW TRANSPLANTATION MARKET RESEARCH PROCESS
• FIGURE 2. BONE MARROW TRANSPLANTATION MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. BONE MARROW TRANSPLANTATION MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. BONE MARROW TRANSPLANTATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BONE MARROW TRANSPLANTATION MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BONE MARROW TRANSPLANTATION MARKET DYNAMICS
• TABLE 7. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY ALLOGENEIC TRANSPLANT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY AUTOLOGOUS TRANSPLANT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY APLASTIC ANEMIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY LEUKEMIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY MYELODYSPLASTIC SYNDROME, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY MYELOMA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY MYELOPROLIFERATIVE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY SICKLE CELL ANEMIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY THALASSEMIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL BONE MARROW TRANSPLANTATION MARKET SIZE, BY MULTI-SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. CANADA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. CANADA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 36. CANADA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 48. AUSTRALIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. AUSTRALIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 50. AUSTRALIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. CHINA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. CHINA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 53. CHINA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. INDIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. INDIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 56. INDIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. INDONESIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. INDONESIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 59. INDONESIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. JAPAN BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. JAPAN BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 62. JAPAN BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. MALAYSIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. MALAYSIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 65. MALAYSIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. PHILIPPINES BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. PHILIPPINES BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 68. PHILIPPINES BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. SINGAPORE BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. SINGAPORE BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 71. SINGAPORE BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. SOUTH KOREA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 73. SOUTH KOREA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 74. SOUTH KOREA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. TAIWAN BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. TAIWAN BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 77. TAIWAN BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. THAILAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. THAILAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 80. THAILAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. VIETNAM BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. VIETNAM BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 83. VIETNAM BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. EUROPE, MIDDLE EAST & AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 86. EUROPE, MIDDLE EAST & AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. EUROPE, MIDDLE EAST & AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 88. DENMARK BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. DENMARK BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 90. DENMARK BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. EGYPT BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. EGYPT BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 93. EGYPT BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. FINLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. FINLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 96. FINLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. FRANCE BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. FRANCE BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 99. FRANCE BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. GERMANY BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 101. GERMANY BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 102. GERMANY BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. ISRAEL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 104. ISRAEL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 105. ISRAEL BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. ITALY BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 107. ITALY BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 108. ITALY BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. NETHERLANDS BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 110. NETHERLANDS BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 111. NETHERLANDS BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. NIGERIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 113. NIGERIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 114. NIGERIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. NORWAY BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 116. NORWAY BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 117. NORWAY BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. POLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 119. POLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 120. POLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. QATAR BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 122. QATAR BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 123. QATAR BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. RUSSIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 125. RUSSIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 126. RUSSIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. SAUDI ARABIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SAUDI ARABIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 129. SAUDI ARABIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 132. SOUTH AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. SPAIN BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 134. SPAIN BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 135. SPAIN BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. SWEDEN BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 137. SWEDEN BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 138. SWEDEN BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. SWITZERLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 140. SWITZERLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 141. SWITZERLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. TURKEY BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 143. TURKEY BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 144. TURKEY BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. UNITED ARAB EMIRATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 146. UNITED ARAB EMIRATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 147. UNITED ARAB EMIRATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 148. UNITED KINGDOM BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 149. UNITED KINGDOM BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 150. UNITED KINGDOM BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 151. BONE MARROW TRANSPLANTATION MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 152. BONE MARROW TRANSPLANTATION MARKET, FPNV POSITIONING MATRIX, 2023

The Bone Marrow Transplantation Market was valued at USD 16.27 billion in 2023, expected to reach USD 17.62 billion in 2024, and is projected to grow at a CAGR of 8.74%, to USD 29.26 billion by 2030.

Bone marrow transplantation (BMT) involves replacing damaged or diseased bone marrow with healthy marrow stem cells, essential for treating conditions such as leukemia, lymphoma, and other blood disorders. It encompasses autologous, allogeneic, and syngeneic transplant types, each serving different clinical requirements, thereby expanding its applicability across various hematological and immune deficiency conditions. The increasing prevalence of these diseases is compelling the necessity and application of BMT, further driven by advancements in medical technology and supportive government policies. Significant growth influences include rising awareness about BMT, improved success rates, and a growing number of stem cell donors. However, the market faces challenges such as high procedural costs, stringent regulations, and the risk of complications like graft-versus-host disease, which can limit its growth trajectory.

The end-use scope primarily spans hospitals, clinics, and specialized cancer treatment centers which are increasingly investing in advanced BMT facilities to enhance treatment efficacy and patient outcomes. Recent market insights reveal that ongoing developments in genetic matching technologies and cryopreservation of stem cells present potential opportunities. Businesses in the sector can capitalize on these trends by focusing on personalized medicine and improving logistics for donor-recipient matching systems. Moreover, innovations in reducing post-transplant complications offer valuable research and development avenues for industry stakeholders. To mitigate limitations, there is a pressing need for cost-effective treatment protocols and patient-centric care models.

The market's nature is dynamic, with a robust inclination towards research in regenerative medicine and genomics, providing fertile ground for innovation. Companies focusing on integration of artificial intelligence in treatment planning and leveraging telemedicine for consultation can enhance accessibility and operational efficiency. By prioritizing collaborations with academic and research institutions to foster innovation, stakeholders can secure a competitive edge. Thus, targeting advancements in immunotherapy, enhancing global donor registries, and investing in public awareness campaigns are strategic steps for capturing emerging market opportunities and driving sustainable growth in the BMT market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bone Marrow Transplantation Market

The Bone Marrow Transplantation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Prevalence of blood cancer and improving accessibility to bone marrow transplantation
  • Increased commercialization of cell therapy and tissue engineering products
  • Government initiatives to improve awareness of the therapy
• Market Restraints
  • High cost of the treatment and lack of reimbursement
• Market Opportunities
  • Technological advancements in bone marrow transplantation therapy
  • Ongoing research & development activities of BMT
• Market Challenges
  • Concerns related to GVHD, infections and relapse

Porter's Five Forces: A Strategic Tool for Navigating the Bone Marrow Transplantation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bone Marrow Transplantation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bone Marrow Transplantation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bone Marrow Transplantation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bone Marrow Transplantation Market

A detailed market share analysis in the Bone Marrow Transplantation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bone Marrow Transplantation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bone Marrow Transplantation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bone Marrow Transplantation Market

A strategic analysis of the Bone Marrow Transplantation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bone Marrow Transplantation Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, American Type Culture Collection, Bayer AG, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bristol Myers Squibb, Eli Lilly and Company, FUJIFILM Cellular Dynamics, Inc., Gamida Cell, Hemacare Corporation, Lifeline Cell Technology, Lonza Group AG, Magenta Therapeutics, Inc., Merck KgaA, Mesoblast Ltd., Novartis AG, PromoCell GmbH, Qiagen N.V., ReeLabs Pvt. Ltd., Sanofi-Aventis LLC, ScienCell Research Laboratories, Inc., and STEMCELL Technologies Inc..

Market Segmentation & Coverage

This research report categorizes the Bone Marrow Transplantation Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Allogeneic Transplant and Autologous Transplant.
• Based on Treatment Type, market is studied across Aplastic Anemia, Leukemia, Lymphoma, Myelodysplastic Syndrome, Myeloma, Myeloproliferative Disorders, Sickle cell Anemia, Solid Tumors, and Thalassemia.
• Based on End-User, market is studied across Ambulatory Surgical Centers, Hospitals, and Multi-Specialty Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Prevalence of blood cancer and improving accessibility to bone marrow transplantation
    • 5.1.1.2. Increased commercialization of cell therapy and tissue engineering products
    • 5.1.1.3. Government initiatives to improve awareness of the therapy
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of the treatment and lack of reimbursement
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in bone marrow transplantation therapy
    • 5.1.3.2. Ongoing research & development activities of BMT
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns related to GVHD, infections and relapse
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Bone Marrow Transplantation Market, by Type

• 6.1. Introduction
• 6.2. Allogeneic Transplant
• 6.3. Autologous Transplant

7. Bone Marrow Transplantation Market, by Treatment Type

• 7.1. Introduction
• 7.2. Aplastic Anemia
• 7.3. Leukemia
• 7.4. Lymphoma
• 7.5. Myelodysplastic Syndrome
• 7.6. Myeloma
• 7.7. Myeloproliferative Disorders
• 7.8. Sickle cell Anemia
• 7.9. Solid Tumors
• 7.10. Thalassemia

8. Bone Marrow Transplantation Market, by End-User

• 8.1. Introduction
• 8.2. Ambulatory Surgical Centers
• 8.3. Hospitals
• 8.4. Multi-Specialty Clinics

9. Americas Bone Marrow Transplantation Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Bone Marrow Transplantation Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Bone Marrow Transplantation Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. American Type Culture Collection
• 3. Bayer AG
• 4. Becton, Dickinson and Company
• 5. Bio-Rad Laboratories, Inc.
• 6. Bristol Myers Squibb
• 7. Eli Lilly and Company
• 8. FUJIFILM Cellular Dynamics, Inc.
• 9. Gamida Cell
• 10. Hemacare Corporation
• 11. Lifeline Cell Technology
• 12. Lonza Group AG
• 13. Magenta Therapeutics, Inc.
• 14. Merck KgaA
• 15. Mesoblast Ltd.
• 16. Novartis AG
• 17. PromoCell GmbH
• 18. Qiagen N.V.
• 19. ReeLabs Pvt. Ltd.
• 20. Sanofi-Aventis LLC
• 21. ScienCell Research Laboratories, Inc.
• 22. STEMCELL Technologies Inc.